Our Releases

Our releases

World Leading Cardiac Specialists Join Celixir Scientific Advisory Board to Form Innovative Cardiovascular Medicines Collaboration
Cardiff , 17/08/2016

Celixir Partners with TMC Life Sciences Bhd and Thomson to Change the Standard of Medical Care for Patients in Southeast Asia.
Cardiff, 05/08/2016

Cell Therapy Rebrands as Celixir
CARDIFF, 20/07/2016

Cell Therapy Ltd Grants Japan License To Daiichi Sankyo For Its Heart Regeneration Medicine, Heartcel™
Cardiff, 10/05/2016

Cell Therapy Ltd announces positive Phase II clinical trial results of Tendoncel™, a first-in-class topical regenerative medicine for severe tendon injury
Cardiff, 30/06/2015

Cell Therapy Ltd announces continuing 100% MACE-free survival after two years average follow up in the Heartcel™ clinical trial in advanced heart failure patients at high risk of incomplete revascularization
Cardiff, 24/06/2015

Cell Therapy Ltd to submit Heartcel™ for conditional marketing authorisation post meeting with the European Medicines Agency
Cardiff, 10/05/2015


Presentations

Presentations

European Society of Gene and Cell Therapy Conference (ESGCT 2016)

Florence, 18 to 21 October 2016

    Presentation by Celixir:

    • Fixing the So-called Unfixable: Regenerating Untreatable Fixed Myocardial Scar in Heart Failure Patients; A. Reginald, S. Sultan, L. Chapman, M. Evans, K, P. Antonitsis, S. Westaby and K. Anastasiadis

    Celixir posters:

    • Immunomodulatory Progenitor Cells: A Novel And Safe Allogeneic Therapy For Patients With Ischaemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting; S. Sultan, A. Reginald, L. Chapman, M. Evans, K, P. Antonitsis, S. Westaby and K. Anastasiadis

    • Tendoncel Phase II Placebo Controlled Randomized Clinical Trial Results For A Novel Allogeneic Regenerative Topical Medicine In Treatment Of Chronic Tendon Injury; A. Reginald, S. Sultan, A. Mousiadou, L. Chapman, M. Evans & G. Panagiotis

International Congress of the European Society for Cardiovascular and Endovascular Surgery, 26th-29th March 2015, Istanbul, Turkey (ESCVS 2015)

Celixir studies presented:

    • ESCVS 2015 Roberts et al. Myocardial Regeneration with Cell Therapy – Heartcel™
The Biology of Regenerative Medicines, 22-24 April 2015, Cambridge, UK

Celixir studies presented:

    • The Biology of Regenerative Medicines 2015 Sultan et al. Isolation of iMP Cells of Mesodermal Lineage From Healthy Peripheral Blood
British Society for Gene and Cell Therapy Annual Conference, 9th-11th June 2015, Strathclyde, Glasgow (BSGCT 2015)

Celixir studies presented:

    • BSGCT 2015 Sultan et al. Isolation of iMP Cells A Novel and Distinct Mesodermal Progenitor Cell
The International Society for Stem Cell Research Annual Meeting, 24th-27th June 2015, Stockholm, Sweden (ISSCR 2015)

Celixir studies presented:

    • ISSCR 2015 Sultan et al. Immunomodulatory Progenitor Cells A Novel Allogeneic Therapy for Patients with Ischaemic Cardiomyopathy undergoing CABG
    • ISSCR 2015 Sultan et al. Isolation of Immunomodulatory Progenitor Cells A Novel and Distinct Mesodermal Progenitor Cell
    • ISSCR 2015 Sultan et al. Tendoncel™ Phase II Placebo controlled Randomized Clinical Trial results of a novel allogeneic regenerative topical medicine in treatment of Chronic Tendon injury
4th International Conference and Exhibition on Cell & Gene Therapy, August 10-12, 2015, London (CGT 2015)

Celixir studies presented:

    • CGT 2015 Reginald et al. A Double Blind Randomised Placebo Controlled Phase IIb Clinical Trial to Study the Efficacy and Safety of Tendoncel™ in Lateral Epicondylitis
European Society of Gene and Cell Therapy Congress, 17-20 September 2015, Helsinki, Finland (ESGCT 2015)

Celixir studies presented:

    • ESGCT 2015 Reginald et al. Tendoncel™ Phase II Placebo controlled Randomized Clinical Trial results of a novel allogeneic regenerative topical medicine in treatment of Chronic Tendon injury
    • ESGCT 2015 Sultan et al. Isolation of immunomodulatory progenitor cells of mesodermal lineage
    • ESGCT 2015 Sultan et al. Immunomodulatory progenitor cells- a novel allogeneic therapy for patients with ischaemic cardiomyopathy undergoing coronary artery bypass grafting

Upcoming Events

Upcoming Events


Factsheets and infographics

Factsheets and infographics

Following are a range of factsheets and infographics for media and other background use – check back soon as we are always adding to our library.


Media enquiries

Media Enquiries

For media enquiries please contact: press@celixir.com